Home > Insider Trading > Filing (0001062993-22-002732)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822691	Greenlight Biosciences Holdings Pbc	GRNA	Biological Products, (No Disgnostic Substances) (2836)	851914700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1908829	Eric Obrien	C/O Greenlight Biosciences Holdings, Pbc 200 Boston Avenue, Suite 3100 Medford MA 02155		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-02-02	8,201,814	$0.00	8,201,814	No	4	A	Indirect	by Fall Line Endurance Fund, LP
Common Stock	Acquisiton	2022-02-02	700,000	$10.00	8,901,814	No	4	P	Indirect	by Fall Line Endurance Fund, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Indirect	by Fall Line Endurance Fund, LP
No	4	P	Indirect	by Fall Line Endurance Fund, LP

Footnotes

Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.
Mr. O'Brien, a director of the Issuer, is the co-founder and Managing Director of Fall Line Endurance Fund, LP and has the power to vote, or to direct the voting of, the shares held by Fall Line Endurance Fund, LP. By virtue of the foregoing, Mr. O'Brien may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the shares held by Fall Line Endurance Fund, LP. Mr. O'Brien disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.
Amount consists of 700,000 shares of common stock issued pursuant to a subscription agreement entered into between the Issuer and Fall Line Endurance Fund, LP.